摘要:
A system includes a control source that is provided on a server and control logic that executes on a terminal. The control logic executes on a terminal to (i) identify a plurality of attributes on the terminal, the attributes including an identifier for each of a plurality of terminal assets that include one or more of a hardware fixture, firmware, or operating system; and (ii) generate signature data from the plurality of attributes. The control source is configured to make a determination from the signature data as to whether the terminal is known or unknown.
摘要:
A system includes a control source that is provided on a server and control logic that executes on a terminal. The control logic executes on a terminal to (i) identify a plurality of attributes on the terminal, the attributes including an identifier for each of a plurality of terminal assets that include one or more of a hardware fixture, firmware, or operating system; and (ii) generate signature data from the plurality of attributes. The control source is configured to make a determination from the signature data as to whether the terminal is known or unknown.
摘要:
A computer-implemented method for alerting passenger vehicles of approaching emergency vehicles is implemented by an alert management computing device. The method includes receiving an emergency vehicle alert request message from an emergency vehicle transmitter, receiving passenger vehicle location data from a plurality of passenger vehicle user computing devices located in a plurality of passenger vehicles, wherein the passenger vehicle location data includes a present passenger vehicle location and a present passenger vehicle trajectory, identifying an alert zone for the emergency vehicle based on the present emergency vehicle location and the present emergency vehicle trajectory, identifying a vehicle zone for each of the plurality of passenger vehicles, identifying a subset of the passenger vehicles within the alert zone by comparing each vehicle zone to the alert zone, and transmitting a warning to the subset of passenger vehicles via the passenger vehicle user computing devices.
摘要:
Customers queuing in the contact center are provided with the option to request a ticket number. Upon a ticket number being generated for the customer, the customer may disconnect or hang up, and an absentee contact is maintained in a queuing system. This allows the customer to reconnect within a predefined period and regain a place in a queue, possibly at a more advantageous position or at the top of the queue. Alternatively, the customer may reconnect at a less favorable position, but without having to re-enter all customer details in order to be allocated to an appropriate queue.
摘要:
The present invention provides methods for optimizing clinical responsiveness to chemotherapy in an individual through genotypic analysis of polymorphisms in at least one gene. The methods of the present invention may further comprise determining the level of at least one long-chain methotrexate polyglutamate (MTXPG) in a sample obtained from the individual. The present invention also provides methods for generating a pharmacogenetic index for predicting clinical responsiveness to chemotherapy in an individual through genotypic analysis of polymorphisms in at least one gene. In addition, the present invention provides methods for optimizing therapeutic efficacy of chemotherapy in an individual by calculating the level of at least one long-chain MTXPG in a sample obtained from the individual.
摘要:
The present invention provides methods for optimizing clinical responsiveness to chemotherapy in an individual through genotypic analysis of polymorphisms in at least one gene. The methods of the present invention may further comprise determining the level of at least one long-chain methotrexate polyglutamate (MTXPG) in a sample obtained from the individual. The present invention also provides methods for generating a pharmacogenetic index for predicting clinical responsiveness to chemotherapy in an individual through genotypic analysis of polymorphisms in at least one gene. In addition, the present invention provides methods for optimizing therapeutic efficacy of chemotherapy in an individual by calculating the level of at least one long-chain MTXPG in a sample obtained from the individual.
摘要:
Computer-implemented methods for allocating risks from major developments are described. The methods include identifying one or more future major developments with economic impact; identifying a parameter to indicate that each of the developments has or has not occurred; creating a contractual instrument that is based on the occurrence or non-occurrence of the one or more major developments; and trading the instrument. A contractual instrument based upon on an occurrence or non-occurrence of one or more major developments in electronic form and tradable in the methods is also described.
摘要:
A preferred embodiment of a hand-held radio frequency identification reader includes a first casing suitable for being grasped by a user, a second casing, and a transceiver housed within one of the first and second casings. The reader also includes an antenna housed within the second casing and communicatively coupled to the transceiver for communicatively coupling the reader to a radio frequency identification tag. The second casing is movably coupled to the first casing so that the second casing can be aligned with the radio frequency identification tag to substantially maximize a read distance of the reader while the first casing is held in a substantially fixed position in relation to the radio frequency identification tag.
摘要:
The present invention provides a compliance system that contains at least one dispenser including at least one individual dose of an anti-folate therapeutic and at least one individual dose of a folic acid analog, each individual dose of anti-folate therapeutic and folic acid analog positioned in one or more individual compartments. Such a dispenser can have, for example, suitable indicia marked in association with each individual compartment, thereby identifying each compartment with the day or time when the enclosed anti-folate therapeutic or folic acid analog should be administered.
摘要:
The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.